We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Actelion revealed that it has entered into exclusive worldwide collaboration with Roche to jointly develop and commercialize its selective S1P1 receptor agonist, an immunomodulator with the potential for once-a-day oral dosing.
Enzo Biochem Inc. said it received a favorable court ruling related to the claim terms in eight patents asserted against defendants Affymetrix, Roche, Amersham, PerkinElmer, Sigma Aldrich, Orchid Biosciences and Molecular Probes.
Forest Laboratories and Lundbeck said July 11 they have filed a patent infringement lawsuit against Caraco Pharmaceutical Laboratories after it applied to market a generic version of the two drugmakers' blockbuster antidepressant Lexapro.
Sen. Chuck Grassley (R-Iowa) has taken his investigation into the FDA's handling of clinical trial fraud to a new level, asking the nation's top law enforcement official to explain why the FDA is refusing to provide access to one of its investigators.
Inex Pharmaceuticals Corporation announced that it anticipates completing the spin-out of the company's technology, products, cash and partnerships into Tekmira Pharmaceuticals Corporation ("Tekmira") by the end of September 2006.